IKF - The Frankfurt Institute of Clinical Cancer Research Revenue and Competitors
Estimated Revenue & Valuation
- IKF - The Frankfurt Institute of Clinical Cancer Research's estimated annual revenue is currently $3.3M per year.
- IKF - The Frankfurt Institute of Clinical Cancer Research's estimated revenue per employee is $88,216
Employee Data
- IKF - The Frankfurt Institute of Clinical Cancer Research has 37 Employees.
- IKF - The Frankfurt Institute of Clinical Cancer Research grew their employee count by 28% last year.
IKF - The Frankfurt Institute of Clinical Cancer Research's People
Name | Title | Email/Phone |
---|
IKF - The Frankfurt Institute of Clinical Cancer Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.4M | 8 | 33% | N/A | N/A |
#2 | $25.1M | 224 | -24% | N/A | N/A |
#3 | $11.2M | 110 | -2% | N/A | N/A |
#4 | $6.3M | 69 | 19% | N/A | N/A |
#5 | $18M | 160 | 24% | N/A | N/A |
#6 | $46.9M | 368 | 13% | N/A | N/A |
#7 | $56.6M | 444 | 9% | N/A | N/A |
#8 | $3.5M | 43 | N/A | N/A | N/A |
#9 | $1M | 17 | N/A | N/A | N/A |
#10 | $5.5M | 60 | N/A | N/A | N/A |
What Is IKF - The Frankfurt Institute of Clinical Cancer Research?
We are a clinical research institution focused on cutting-edge,\nindustry-academia collaborative and investigator-sponsored cancer research.\nAs such, we provide clinical researchers and science-driven biotech\ncompanies a professional platform built on profound oncology expertise and\npowerful networks, for planning and conducting of high-end clinical studies.\nOur mission is to advance scientifically motivated clinical cancer research.\n\nFormal name: Institut für Klinische Krebsforschung IKF GmbH
keywords:N/AN/A
Total Funding
37
Number of Employees
$3.3M
Revenue (est)
28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.3M | 37 | N/A | N/A |
#2 | $4.3M | 37 | 16% | N/A |
#3 | $6.2M | 37 | 3% | N/A |
#4 | $5.2M | 37 | 6% | N/A |
#5 | $6.2M | 38 | 65% | N/A |